Exact Sciences plans to expand its sales force by 200 employees, ramp up its digital and social media marketing campaigns, and introduce a new “national celebrity spokesperson” this year, as the company seeks to increase sales of its flagship product, a stool-based DNA test for colorectal cancer.
Madison, WI-based Exact (NASDAQ: EXAS) detailed some of its plans for 2018 and beyond in a corporate presentation the company will give on Tuesday at the J.P. Morgan Healthcare Conference in San Francisco.
As it did last year, Exact released preliminary figures related to the company’s financial and business performance for the… Read more »
UNDERWRITERS AND PARTNERS